GMAB - Genmab AS - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMAB is currently covered by 3 analysts with an average price target of $40.27. This is a potential upside of $6.71 (19.99%) from yesterday's end of day stock price of $33.56.

Genmab AS's activity chart (see below) currently has 77 price targets and 62 ratings on display. The stock rating distribution of GMAB is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.18% with an average time for these price targets to be met of 53.69 days.

Highest price target for GMAB is $47, Lowest price target is $20, average price target is $33.5.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Oct-2025.

Currently out of the existing stock ratings of GMAB, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

$6.44 (19.19%)

$50

4 days ago
(01-Oct-2025)

9/18 (50%)

$7.88 (24.53%)

131

Buy

$27

$-2.07 (-7.12%)

$31

7 months 22 days ago
(13-Feb-2025)

5/5 (100%)

$6.08 (29.06%)

179

Hold

$20

$-13.56 (-40.41%)

$30

7 months 23 days ago
(12-Feb-2025)

3/3 (100%)

$-0.92 (-4.40%)

208

Buy

$47

$13.44 (40.05%)

$48

8 months 7 days ago
(28-Jan-2025)

1/4 (25%)

$27.15 (136.78%)

26

Hold

$31

$1.93 (6.64%)

$31

1 years 24 days ago
(11-Sep-2024)

0/2 (0%)

$4.07 (15.11%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMAB (Genmab AS) average time for price targets to be met?

On average it took 53.69 days on average for the stock forecasts to be realized with a an average price target met ratio 31.18

Which analyst has the current highest performing score on GMAB (Genmab AS) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on GMAB (Genmab AS)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on GMAB

Which analyst is the currently most bullish on GMAB (Genmab AS)?

Asthika Goonewardene with highest potential upside - $16.44

Which analyst is the currently most reserved on GMAB (Genmab AS)?

Yaron Werber with lowest potential downside - -$13.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?